T rauma patients are at risk for the development of adult respiratory distress syndrome (ARDS). Specifically, many trauma patients have well-documented risk factors for ARDS including polytrauma with Injury Severity Score (ISS) of greater than 16, thoracic injury or pulmonary contusions with a chest Abbreviated Injury Scale (AIS) score of greater than 3, longbone and pelvic fractures, positive fluid balance of more than 2 L at 48 hours after injury, and transfusion of more than 2 U of blood products within the first 24 hours of injury.
1Y6 When these insults are coupled with early mechanical ventilation (i.e., high tidal volume and low positive end-expiratory pressure), ARDS can develop rapidly. 2, 7, 8 In particular, patients with severe trauma frequently undergo emergent operative procedures and can remain on mechanical ventilation several days postoperatively for airway protection and postoperative respiratory failure. 9 As many as 24% of patients admitted to the hospital without acute lung injury (ALI) that receive routine mechanical ventilation develop ALI within 48 hours, 8 with greater than 80% progressing to ARDS. 10 In trauma patients, the lung is the organ that most often fails, 3,7,8,11Y13 and when combined with other organ failure, mortality accelerates. 3, 5, 6, 11, 14, 15 Recent literature spanning 30 years of clinical research documents that nearly all clinical treatment trials for established ARDS have had unimpressive outcomes. 16, 17 In fact, despite the era of lung protective strategies, several recent studies suggest that ARDS mortality seems essentially unchanged since 1994 3, 7, 11 and remains unacceptably high (35Y45%). 11, 13, 18, 19 The consistently poor clinical performance of various treatment strategies for ARDS suggests that perhaps the timing of intervention is too late in the course of ARDS pathogenesis to succeed.
Patients are generally transitioned to protective ventilation after ARDS has developed. This late transition may exacerbate lung injury and perpetuate ARDS development. 7 In fact, the majority of patients develop ARDS within 48 hours of admission, suggesting that early intervention with a preemptive ventilator strategy before ARDS has developed may prevent the progression of lung injury. 20 Preemptive mechanical ventilation strategies applied before ARDS is established could transform the clinical paradigm from treating ARDS to preventing ARDS from occurring.
We hypothesized that early application of airway pressure release ventilation (APRV) before ARDS development in high-risk trauma patients could reduce ARDS-related mortality by reducing the incidence of ARDS as compared with patients receiving conventional ventilation.
PATIENTS AND METHODS
Detailed description of methods is available in an online Supplement, http://links.lww.com/TA/A291. The R Adams Cowley Shock Trauma Center in Maryland is a high-volume academic trauma center. A systematic review was conducted to evaluate outcomes for patients with early application of APRV at the Shock Trauma Center, comparing populations admitted with other trauma centers. Relevant studies were identified through a PubMed and MEDLINE search from 1995 to 2012 using keywords trauma and acute respiratory distress syndrome or ARDS and trauma and acute lung injury or ALI. Inclusion criteria were published prospective and retrospective observational and cohort studies enrolling 100 or more adult trauma patients with reported ALI/ARDS incidence and in-hospital mortality data. Randomized controlled trials and studies not exclusively of trauma patients were excluded. Our study was limited to observational data to better reflect ''real-world'' practice and mortality. Titles, abstracts, and full-text copies were independently reviewed in detail by two authors (J.R.S. and E.J.-K.). In addition, any outliers underwent secondary analysis to ensure data homogeneity (see Supplement, http://links.lww.com/TA/A291).
After approval by the hospital's institutional review board, a retrospective analysis of patient records and trauma database was conducted for 2002 to 2005 corresponding with the timing of APRV application (early APRV) using an established method. 21 Inclusion criteria were as follows: polytrauma patients aged 16 years to 65 years, ISS of greater than 17, and at least one femoral shaft fracture. The data for this group were derived from a previously published study conducted during a 3-year period. 22 The current study is a secondary analysis of this previous patient group, which introduces new study variables and analyses. Primary outcome measures were as follows: development of ARDS per AmericanEuropean Consensus Conference definition (PaO 2 /FIO 2 G 200), in-hospital mortality (death within the same hospital admission), and ARDS-related mortality (death associated with ARDS). Independent ARDS risk factors 5, 6 and the Lung Injury Prediction Score (LIPS) 23 were evaluated to verify the high risk of ARDS for included patients.
Statistical Analysis
In a systematic review, we combined data from the included studies and evaluated the distribution of variables such as mean ISS, ARDS incidence, and mortality. In addition, a new variable called Therapy Performance Score was derived as the product of (%mortality Â %ARDS) / mean ISS, to express the relationship between ISS, ARDS incidence, and mortality for each trauma center. Specifically, the Therapy Performance Score would assume the lowest value for the most successful strategy, resulting in the fewest ARDS cases and least mortality in the presence of high ISS scores. In contrast, Therapy Performance Score would be the worst if its values were high owing to high ARDS incidence and high %mortality regardless of low ISS values.
The goal of the systematic review was to identify these trauma centers that represented the extreme values and outliers causing data heterogeneity. Distributions of variables were analyzed using SPSS Statistics 19. A distribution was considered normal when Kolmogorov-Smirnov and Shapiro-Wilk normality tests each returned p 9 0.05. Boxplots were used to present data centered on median. Trauma centers representing the extreme values or outliers were evaluated for their effect on data heterogeneity using W 2 test during meta-analysis. Specifically, the following parameters were calculated for ISS and Therapy Performance Score: (i) weights for effect sizes for individual studies, using the formula for inverse variance weight based on random effects variance component; (ii) weighted mean effect sizes for included studies; (iii) 95% confidence interval (CI) for included studies; and (iv) Q value for included studies. Data were assumed homogenous if calculated Q was less than the critical value for W 2 at p = 0.05. Heterogeneity (if occurred) was further investigated in sensitivity studies where Q values were calculated for data sets without the outliers suspected to introduce the excess variation.
During data extraction, raw (not weighted) data were obtained, and missing data were substituted by calculating values based on numbers reported in the same study, that is, (1) number of ARDS patients was calculated from ARDS% and the total number of patients included in a study (n ARDS = %ARDS Â n total ); (2) mean ISS score for combined data set was calculated from individual mean ISS scores of reported subgroups a and b using number of scores (n) in subgroups as follows: mean ab = [(mean a Â n a ) + (mean b Â n b )]/(n a + n b ); (3) SD for combined data set was calculated using the formula for variance (s2) of combined data sets given individual means, SDs (s), and numbers of scores (n) from reported subgroups a and b, ]; (4) SD was calculated from the reported SE for a given n, using the formula SE Â SQRT(n); (5) given interquartile range, SD was estimated based on a formula where R = 0.7413 Â interquartile range. Final strata (all data sets combined) was composed of the following: overall number of critically ill trauma patients with ISS of greater than 17 included in a study (overall no.), mean ISS score for the overall group of patients included in a study (overall mean ISS), SD for overall mean ISS score (overall ISS SD), number of patients included in the study who developed ARDS (ARDS no.), ARDS incidence calculated as a ratio of ARDS patients to the overall number of patients included in a study (ARDS %), number of patients who died within the first hospital admission (mortality no.), mortality percentage calculated as a ratio of patients who died in the hospital to the overall number of patients included in a study (mortality %).
RESULTS

Systematic Review
Among 767 articles identified through a MEDLINE and PubMed search between 1995 and 2012, 21 were screened, and 2 were excluded for describing randomized clinical trials. Nineteen full-text articles were assessed for eligibility criteria; none was excluded for ISS of less than 17, none did not meet age criteria, one reported populations of less than 100, and three did not describe exclusively trauma patients. As a result, 16 articles (including this current early APRV group) totaling 66,199 patients were included in qualitative analysis, 16 were included in meta-analysis for mean ISS, and 15 were included in meta-analysis of the therapy performance product.
1Y3,10,24Y34
Characteristics of included studies and our early APRV group are presented in Table 1 , and characteristics of the patients in the included studies are reviewed in Table 2 .
Meta-analysis revealed that ISS were comparable in all selected studies with calculated mean ISS of 25.72, SE of mean ISS of 1.02, and 95% CI between 23.73 and 27.72. Analysis of data homogeneity using random effects model confirmed that individual ISS did not significantly differ from the calculated mean ISS (see supplement, http://links.lww.com/TA/A291). The ISS of 29 for the early APRV group scored above the upper boundary of the calculated 95% CI and fell in the upper quartile of the boxplot for mean ISS distribution across the selected studies (Fig. 1) . The data for ARDS incidence were normally distributed, with the mean value of 14.02%, SEM of 2.42%, and the 95% CI with the lower boundary of 8.86% and the upper boundary of 19.18%. The early APRV group had the lowest incidence of ARDS among all selected studies (Fig. 1) . The percentage of in-hospital mortality showed normal distribution with a mean of 14.14%, SE of 1.75%, and the 95% CI ranging from 10.39% to 17.89%. The early APRV group showed the lowest in-hospital mortality rate at 3.9% (Fig. 1) .
To evaluate therapy performance, we calculated the product of [(mortality% Â ARDS%) / mean ISS] for all individual studies selected for the review. The highest score represented the worst performance where population of less injured patients had high in-hospital mortality% and high ARDS%. The lowest score represented the best performance where population of highly injured patients had low in-hospital mortality% and low ARDS%. The middle range score demonstrated those studies that showed simple correlation of worse outcome with higher ISS scores. Despite the high ISS score, the early APRV group represented the extreme minimum value of 0.175 on the boxplot for therapy performance, indicating the most successful outcome for one of the highest ISS among all reviewed articles. To further assess the degree to which the early APRV group was at risk of ARDS, we used the LIPS calculation worksheet to score patients. The early APRV group had a mean of 8.7, which represents the highest end of the LIPS scale. Another factor that could potentially affect the traumarelated ARDS mortality is ventilation strategy. In the 15 studies analyzed, we were unable to determine if all patients received lung protective low-tidal volume ventilation. Therefore, to assess the impact of low-tidal volume ventilation on trauma-related ARDS mortality, we analyzed data from the ARDSnet trials. 35 Although trauma-related ARDS was poorly represented in the ARDSnet trials (less than 4%, 170 of 4,341 patients), 35 low-tidal volume ventilation applied in trauma-related ARDS resulted in a mortality of 12% 36 and was within the range of the mortality rate in our meta-analysis. These data of trauma ARDSnet trial patients were more than threefold higher than the in-hospital mortality observed in patients treated with our early APRV group.
DISCUSSION
The most important finding in this study was that the early use of APRV reduced both incidence and mortality associated with ARDS as compared with applying conventional mechanical ventilation for treatment of ARDS (systematic review).
The concept of preventing ARDS has been discussed by others 37 and is reflected in the evolution of our ventilatory management, changing from treatment toward prevention of ARDS in trauma patients. Between 1992 and 1995, trauma patients in our institution received APRV later in the course of respiratory failure. During this period, APRV was generally applied after lung injury had already developed, as a rescue mode or during extracorporeal membrane oxygenation. 38 As the APRV use expanded to a standard-of-care mode of ventilation within our institution, we observed a decrease in ARDS incidence from 9.3% to 1.3% and that ARDS-related mortality decreased from 23.5% to 0%. 39 Early (prevention) application of APRV illustrates a fundamental concept that timing of an intervention may be as critical as the intervention itself.
Systematic review compared our outcomes with that reported by other trauma centers. Analysis revealed that despite the high mean value of our ISS of 29 scoring above the upper boundary of 95% CI for the reviewed studies (23.7Y27.7) (Fig. 1) , our ARDS incidence (1.3%) (Fig. 1 ) and in-hospital mortality (3.9%) (Fig. 1) represented the extreme lowest scores. Importantly, those in-hospital deaths were not related to ARDS. These data suggest that the early APRV strategy was associated with the most successful outcome in trauma patients and ARDS may be prevented if appropriate ventilator strategies are applied before clinically evident lung injury has developed (Fig. 2) .
Although populations of patients described in selected studies had comparable ISS scores (Fig. 1) , we further compared risk factors for ARDS among the early APRV group to relate the expected incidence and ARDS-associated mortality against actual results. To minimize false positive results in our study, we evaluated a population at high risk of developing ARDS. Specifically, we considered the severity of global and local injury as well as subsequent resuscitative care to identify independent risk factors for ARDS and death. 1, 2, 10, 40 An ISS range of 16 to 27 is highly predictive of ARDS. 1, 40 Several studies have confirmed the association between the severity of injury (specifically chest trauma and femur fractures) and the risk of developing ARDS. 1, 10, 14, 23, 33 The early APRV group experienced polytrauma, including extremity fractures and chest, abdominal, spinal, and brain injuries with the ISS range of 17 to 66, increasing their risk for ARDS development. We further identified several independent risk factors associated with ARDS. In particular, resuscitative care and transfusion of packed red blood cells, and fresh frozen plasma (FFP) are all independently associated with the development of ARDS in trauma patients, 4 ,6,40Y42 including transfusion-related ALI. Our patients that received packed red blood cells (58%) and FFP (45%) had a mean of 7.6 U and 8.6 U, respectively, transfused in the first 24 hours. In addition, a positive fluid balance in the first 24 hours to 48 hours is associated with ARDS development, particularly with crystalloid resuscitation. 10 Our patients received a mean of 11.5 L of crystalloids in addition to blood products in the first 24 hours (Table 3) .
To insure that these patients were at high risk for ARDS, we scored the early APRV group with a recently validated LIPS. 23 A calculated LIPS of greater than 8 is associated with an ARDS incidence of more than 35%. Based on the LIPS calculation worksheet, the early APRV group had a mean LIPS of 8.7, with an actual ARDS incidence of 1.3%. 23 Because the average LIPS was more than 8 in the early APRV group and the LIPS has a high negative-predictive value, we believe we evaluated a group of trauma patients at high risk for the development of ALI/ARDS. The high mean LIPS (8.7) in the early APRV group further supports that our results are not caused by a false positive. Although LIPS validates a wide spectrum of patient types including trauma and surgical patients, it potentially underscores trauma patients, particularly those with nonoperative blunt abdominal trauma, a group at risk of developing the systemic inflammatory response syndrome, shock, sepsis, and multiple-organ dysfunction syndrome. 13, 14 In the early APRV group, 23% experienced nonoperative blunt abdominal trauma with an AIS score of greater than 2. Therefore, it is likely the LIPS may have underestimated ARDS prediction in our patients.
These clinical observations are further supported by our recently published laboratory studies using a translational 48-hour porcine model of fecal peritonitis and gut ischemiareperfusionYinduced ARDS. 43, 44 These studies demonstrate that early APRV strategy applied immediately following fecal peritonitis + ischemia-reperfusion injury prevented ARDS. More specifically, early APRV strategy prevented distal airspace edema, alveolar protein exudation, limited surfactant degradation, reduced lung inflammation, and preserved normal lung architecture, as compared with animals receiving nonprotective conventional volume ventilation (tidal volume of 10 mL/kg and a positive end-expiratory pressure of 5 cm H 2 O) 43 or ARDSnet strategy low-tidal volume ventilation. 44 Both nonprotective and ARDSnet ventilation groups developed fully expressed ARDS clinically determined by PaO 2 /FIO 2 ratio of less than 200, and with lung histopathology, systemic and pulmonary inflammation and a high ARDS-related mortality. 43, 44 Both of these studies used a well-established porcine model of multiple-organ dysfunction syndrome and ARDS, demonstrating ''good evidence'' that effective treatment in this model would translate into effective clinical treatment.
The concept of a preemptive ventilation strategy is obverse to the current understanding that the ventilator produces or propagates lung injury. 8 Although both concepts may be true, the more significant detail may be the method of ventilation and the point of application in the pathogenesis of the disease (i.e., early vs. late). The key role of mechanical ventilation may lie in whether progressive alveolar instability and heterogeneity is propagated or prevented. 43, 44 Instead of the ventilator causing or advancing lung injury, 8 the ventilator may be used to halt the progression of the looming pathophysiology. 43, 44 The maximum ISS was reported by Dicker at 32. 9, The mean ISS of 29 for the preemptive APRV group belonged to the upper quartile of the boxplot. ARDS incidence % shows the range and distribution of scores reported by 16 authors; 50% of them reported ARDS incidence between 22.5% and 6%, with the middle score of 11.95% (median). The maximum incidence of ARDS was reported by Shah et al. at 34.1%. 9, The incidence of ARDS in the preemptive APRV group represented the minimum score at 1.3%. Mortality % shows the range and distribution of mortality scores reported by 16 authors; 50% of them reported mortality between 18.2% and 9.2%, with the middle score of 13.9% (median). The maximum mortality was reported by Salim et al. at 25 .3%. 9, The preemptive APRV group scored the minimum mortality rate of 3.9%.
Limitations
Our study has the same limitations inherent to all retrospective studies. It should also be noted that the patients analyzed in the present study might have received conventional mechanical ventilation modes before admission to the intensive care units (ICUs) at our trauma center or in other units of our facility. Conversely, although it is possible that APRV was used in a small percentage of the patients included in the comparison studies in Table 1 , it is probable that if used at all, it was applied as a ''rescue therapy'' only after the patient had already developed ARDS criteria.
CONCLUSION
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